The PEMFs + hASCs kept in OM reported a strong increase in col1a1 expression already at 7 days of treatment, as the commitment towards the osteogenic process probably started earlier, due to the administration of dexamethasone, ascorbic acid, and β-glycerophosphate. This evidence concerns the gene COL1A1 and ocular melanoma.